NCT00265928 2008-01-28Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Terminated46 enrolled
NCT00077493 2007-12-28BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaMedImmune LLCPhase 1 Suspended95 enrolled